Surfaxin is a medication that is used to treat respiratory distress syndrome (RDS) in premature infants. This condition occurs when a baby’s lungs are not fully developed and are unable to produce enough surfactant, a substance that helps the lungs expand and contract properly. Surfaxin works by replacing the missing surfactant in the lungs, allowing the baby to breathe more easily.

It is important to follow the dosing instructions provided by your healthcare provider when using Surfaxin. This medication is typically administered directly into the baby’s lungs through a tube inserted into the windpipe. Your healthcare provider will monitor your baby closely while they are receiving Surfaxin to ensure that they are responding well to the treatment.

Like all medications, Surfaxin can cause side effects. Common side effects may include changes in breathing, increased heart rate, and changes in blood pressure. It is important to notify your healthcare provider if you notice any unusual symptoms in your baby while they are receiving Surfaxin.

Overall, Surfaxin is a valuable medication that can help improve the breathing function of premature infants with RDS. If you have any questions or concerns about this medication, do not hesitate to speak with your healthcare provider. They can provide you with more information about Surfaxin and help you determine if it is the right treatment option for your baby.